Nashville Biosciences, a wholly-owned subsidiary of Nashville, Tenn.-based Vanderbilt University Medical Center, is collaborating with Standigm, a company that uses artificial intelligence for drug discovery and development, to customize AI models for drug discovery.Standigm will create advanced AI models using Nashville Biosciences’ de-identified genomic and clinical data. The data sets will help identify therapeutic targets, […]